Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
BiomX (PHGE) PT Lowered to $16 at Chardan Capital Markets
-
Blockchain Moon Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Blockchain Moon Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Form S-1/A CHARDAN NEXTECH ACQUISIT
-
IPO for SPAC Achari Ventures Holdings Corp. I (AVHI) Opens at $10.05
-
Achari Ventures Holdings Corp (AVHIU) Prices 10M Unit IPO at $10/unit
-
Achari Ventures Holdings Corp. I Announces Pricing of $100 Million Initial Public Offering
-
Best Penny Stocks To Buy This Week? 10 With Potential Biotech Catalysts
-
Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Units
-
Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Scout Bio to Present at Upcoming October Investor Conferences
-
Scout Bio to Present at Upcoming October Investor Conferences
-
Clinical Data on GenSight Biologics’ LUMEVOQ® and GS030 Gene Therapies to be Presented at 2021 ASRS, ESGCT and Several Investor and Industry Meetings in October
-
Krystal Biotech to Present at the Chardan 5th Annual Genetic Medicines Conference
-
UPDATE: Chardan Capital Markets Starts Renovacor, Inc. (RCOR) at Buy
-
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
-
Monterey Bio Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering
-
SQZ Biotechnologies to Present at the Chardan 5th Annual Genetic Medicines Conference
-
Celsion to Present at Three Investment Conferences in October
-
Celsion to Present at Three Investment Conferences in October
-
Mustang Bio to Participate in Chardan’s Virtual 5th Annual Genetic Medicines Conference
-
Mustang Bio to Participate in Chardan’s Virtual 5th Annual Genetic Medicines Conference
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
-
uniQure to Participate in Multiple Upcoming Industry Conferences in October
-
Rocket Pharmaceuticals to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Sensorion to Attend Three Conferences in October 2021, Including the Cell & Gene Meeting on the Mesa
-
Flamingo Therapeutics to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
-
4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
-
Arrowhead Pharmaceuticals to Participate in Upcoming October 2021 Conferences
-
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
-
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
-
Renovacor to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
NeuBase to Participate at the Chardan 5th Annual Genetic Medicines Conference
-
Taysha Gene Therapies to Participate in Upcoming October Investor Healthcare Conferences
-
Alnylam to Webcast Presentation at Chardan Virtual 5th Annual Genetic Medicines Conference
-
Moderna to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
-
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
-
ReCode Therapeutics Announces Participation in Upcoming October Investor Conferences
-
Cabaletta Bio to Present at the Chardan 5th Annual Genetic Medicines Conference
-
Arbutus to Participate in October Investor Conferences
-
Arbutus to Participate in October Investor Conferences
-
Gennao Bio to Participate in Chardan’s 5th Annual Genetic Medicines Conference
-
TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference
-
Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference
-
TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference
-
Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference

